Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Northam Platinum (NPHJ.J)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (RCnt) Price Target (RCnt) Rating
2022-03-302246020000Sell
2022-04-042071016000Sell
2022-07-061774015000Sell
2022-08-291604814000Sell
2022-10-131717015000Sell
2022-12-131928216500Sell
2023-03-291513313000Sell
2023-06-271270312500Sell
2023-08-021388413500Sell
2023-08-301308911000Sell
2023-10-161283012000Sell
2023-11-141167111000Sell
2024-03-011045510000Sell
2024-04-091387813000Sell
2024-08-291162112500Sell
2024-09-0595009500Sell
2025-03-141189410500Sell
2025-04-151358511000Sell

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.